Akèy › Kansè nan tete › Illinois › Champaign
Etid klinik pou Kansè nan tete nan Champaign, IL
11 etid pou Kansè nan tete ap chèche patisipan nan sit nan ak bò kote Champaign (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Carle Cancer Center, Urbana · 2 mi lwen
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Ap rekriteFaz 3
- Clinical Trial Site, Urbana · 2 mi lwen
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
Ap rekriteFaz 3
- Carle Foundation Hospital d/b/a Carle Cancer Center, Urbana · 2 mi lwen
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
Ap rekriteFaz 1/2
- Carle Cancer Center, Urbana · 2 mi lwen
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Ap rekriteFaz 3
- Carle Cancer Center, Urbana · 2 mi lwen
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Ap rekriteFaz 3
- Carle Cancer Center, Urbana · 2 mi lwen
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Ap rekriteFaz 3
- Carle Foundation Cancer Institute-Urbana, Urbana · 2 mi lwen
E-Mindfulness Approaches for Living After Breast Cancer
Ap rekriteFaz 3
- Carle Cancer Center, Urbana · 2 mi lwen
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Ap rekriteFaz 3
- Carle Cancer Center, Urbana · 2 mi lwen
- The Carle Foundation Hospital, Urbana · 2 mi lwen
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Ap rekriteEtid obsèvasyon
- Carle Cancer Center, Urbana · 2 mi lwen
Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss
Ap rekrite
- Carle Health, Urbana · 2 mi lwen
Etid Kansè nan tete nan lòt vil
- New York City, NY134 etid
- Houston, TX126 etid
- Boston, MA111 etid
- Nashville, TN80 etid
- Los Angeles, CA72 etid
- Edison, NJ68 etid
- St. Louis, MO64 etid
- Durham, NC63 etid
- Queens, NY63 etid
- Chicago, IL58 etid
- Philadelphia, PA56 etid
- Dallas, TX55 etid
Lòt etid nan Champaign
- Kansè Poumon ki pa ti selil11 etid
- Kansè poumon9 etid
- Kansè pwostat8 etid
- Kansè Endomèt6 etid
- Kansè (tout kalite)6 etid
- Karsinòm selil skuamèz tèt ak kou6 etid
- Melanom6 etid
- Kansè kolorektal6 etid
- Kansè larinks5 etid
- Kansè bouch5 etid
- Kansè renn (Kasinom selil renn)5 etid
- Kansè pankreyas5 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.